1,345 results on '"MacGregor, G"'
Search Results
152. Salt--overwhelming evidence but still no action: can a consensus be reached with the food industry? CASH (Consensus Action on Salt and Hypertension)
153. PO46 Young women with breast cancer do well following immediate breast reconstruction in a networked regional-tertiary service
154. 297 Health care professionals’ appreciation of the challenges of concordance to therapies in CF
155. Plasma sodium and blood pressure in individuals on haemodialysis
156. Nutrition in cardiovascular disease: salt in hypertension and heart failure
157. 148 The influence of moulds as an independent risk factor for decreasing lung function in cystic fibrosis
158. Regulatory toxicology and pharmacology.
159. ALTERING PLASMA SODIUM CONCENTRATION RAPIDLY CHANGES BLOOD PRESSURE DURING HAEMODIALYSIS: PP.23.420
160. Promoting weight gain with olanzapine in underweight adults with cystic fibrosis
161. MODEST SALT REDUCTION LOWERS BLOOD PRESSURE AND URINARY ALBUMIN EXCRETION IN IMPAIRED GLUCOSE TOLERANCE AND TYPE 2 DIABETES: 5A.01
162. Can modern nebulisers improve patient outcomes?
163. A comprehensive review on salt and health and current experience of worldwide salt reduction programmes
164. Salt intake and cardiovascular disease
165. Regional left ventricular deformation and geometry analysis provides insights in myocardial remodelling in mild to moderate hypertension
166. Salt and blood pressure in children and adolescents
167. Salt and blood pressure in children: reply to commentary by Alderman
168. Fabrication and properties of gallium phosphide variable colour displays
169. 827 Regional left ventricular deformation and geometry in mild to moderate hypertension
170. 500 Changes in regional left atrial deformation in hypertension
171. 496 A longitudinal study of bone mineral density change in adults with Cystic Fibrosis
172. Blood Pressure— Importance of Salt Intake
173. Breath condensate ammonium is lower in children with chronic asthma
174. Importance of controlling blood pressure
175. App-Based Salt Reduction Intervention in School Children and Their Families (AppSalt) in China: Protocol for a Mixed Methods Process Evaluation
176. PLASMA SODIUM-IGNORED AND UNDERESTIMATED
177. EFFECT OF POTASSIUM CHLORIDE AND POTASSIUM CITRATE ON BLOOD PRESSURE IN PATIENTS WITH UNTREATED ESSENTIAL HYPERTENSION
178. EFFECT OF AN ANGIOTENSIN II ANTAGONIST IRBESARTAN ON BLOOD PRESSURE AND SKIN CAPILLARY DENSITY IN PATIENTS WITH ESSENTIAL HYPERTENSION
179. ORTHOGONAL POLARIZATION SPECTRAL (OPS) IMAGING OF CAPILLARY MICROCIRCULATION IN AFROCARRIBEAN AND CAUCASIAN SUBJECTS WITH ESSENTIAL HYPERTENSION
180. SKIN CAPILLARY DENSITY IN HYPERTENSIVE AND NORMOTENSIVE INDIVIDUALS AND ITS CORRELATION WITH PLASMA RENIN ACTIVITY AND AMBULATORY BLOOD PRESSURE
181. Long term effects of advice to reduce dietary salt
182. An extreme bias in the germ line of XY C57BL/6XY FVB/N chimaeric mice
183. Sodium and blood pressure
184. Fortnightly review: Beneficial effects of potassium
185. Comparison of nasal pH values in black and white individuals with normal and high blood pressure
186. EFFECT OF LONGER-TERM MODEST SALT REDUCTION ON BLOOD PRESSURE. A META-ANALYSIS. IMPLICATIONS FOR PUBLIC HEALTH
187. REDUCING SODIUM INTAKE REDUCES URINARY CALCIUM LOSSES IN THE ELDERLY
188. "Salt": a commentary
189. British Hypertension Society guidelines for hypertension management 1999: summary
190. Developmental regulation of Bcl-2 family protein expression in the involuting mammary gland
191. Reducing Salt Intake in China with 'Action on Salt China' (ASC): Protocol for Campaigns and Randomized Controlled Trials
192. Tony Raine memorial lecture. Salt: blood pressure, the kidney, and other harmful effects
193. The use of HMG Co-A reductase inhibitors following acute myocardial infarction in hospital practice
194. Abnormalities of nasal potential difference measurement in Liddle's syndrome.
195. High prevalence of carotid artery disease in patients with atheromatous renal artery stenosis
196. Rebound sodium and water retention occurs when diuretic treatment is stopped
197. Salt—More Adverse Effects
198. The use of angiotensin-converting enzyme inhibitors in the treatment of heart failure in hospital practice
199. D29 The efficacy of candesartan; an angiotensin II type I receptor antagonist alone or in combination with amlodipine or in combination with amlodipine and hydrochlorothiazide in patients with moderate-to-severe essential hypertension
200. Deterioration in renal function with enalapril but not losartan in a patient with renal artery stenosis in a solitary kidney.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.